2006
Usefulness of Routine Unfractionated Heparin Infusion Following Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction in Patients Not Receiving Glycoprotein IIb/IIIa Inhibitors
Harjai KJ, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Na Y, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Rutherford BD, Lansky AJ, Mehran R. Usefulness of Routine Unfractionated Heparin Infusion Following Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction in Patients Not Receiving Glycoprotein IIb/IIIa Inhibitors. The American Journal Of Cardiology 2006, 99: 202-207. PMID: 17223419, DOI: 10.1016/j.amjcard.2006.07.084.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyPrimary percutaneous coronary interventionGlycoprotein IIb/IIIa inhibitorsIIb/IIIa inhibitorsAcute myocardial infarctionPercutaneous coronary interventionHeparin usePostprocedural heparinCoronary interventionMyocardial infarctionHospital major adverse cardiac eventsPrimary PCIMajor adverse cardiac eventsUnfractionated heparin infusionAdverse cardiac eventsOutcomes of patientsSubset of patientsTransluminal coronary angioplastyLate MACEPostprocedure courseHeparin infusionCardiac eventsCoronary angioplastyCoronary stentingSevere bleeding
2003
Outcomes following Bail-Out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial)
Ashby DT, Aymong EA, Tcheng JE, Grines CL, Cox DA, Mehran R, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Lansky AJ, Stone GW. Outcomes following Bail-Out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial). The American Journal Of Cardiology 2003, 92: 1091-1094. PMID: 14583362, DOI: 10.1016/j.amjcard.2003.06.005.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAgedAngioplasty, Balloon, CoronaryAntibodies, MonoclonalCross-Over StudiesDrug Administration ScheduleFemaleFollow-Up StudiesHumansImmunoglobulin Fab FragmentsIntraoperative ComplicationsMaleMiddle AgedMyocardial InfarctionPlatelet Glycoprotein GPIIb-IIIa ComplexProspective StudiesTreatment FailureConceptsAcute myocardial infarctionMyocardial infarctionGlycoprotein IIb/IIIa receptor inhibitorsUnsuccessful primary percutaneous coronary interventionIIb/IIIa receptor inhibitorsMyocardial Infarction (TIMI) grade 3 flowPrimary percutaneous coronary interventionGrade 3 flowPercutaneous coronary interventionSuboptimal angioplasty resultsAbciximab administrationCADILLAC trialIschemic complicationsControl patientsCoronary interventionProcedural complicationsAngioplasty resultsReceptor inhibitorsPrimary interventionAbciximabPatientsComplicationsInfarctionLower ratesInterventionOutcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial)
Ashby DT, Aymong EA, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Carroll JD, Turco M, Lansky AJ, Stone GW. Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial). The American Journal Of Cardiology 2003, 92: 1095-1098. PMID: 14583363, DOI: 10.1016/j.amjcard.2003.06.006.Peer-Reviewed Original ResearchConceptsSuccessful balloon angioplastyAcute myocardial infarctionBalloon angioplastyRoutine stentingMyocardial infarctionEvent-free survivalPrimary balloon angioplastySuboptimal balloon angioplastyCADILLAC trialUnsuccessful dilatationPrimary interventionAngioplastyStentingInfarctionPatientsDilatationTrials
2001
Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis
Han R, Schwartz R, Kobayashi Y, Wilson S, Mann J, Sketch M, Safian R, Lansky A, Popma J, Fitzgerald P, Palacios I, Chazin-Caldie M, Goldberg S, in the Appendix. F. Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis. The American Journal Of Cardiology 2001, 88: 253-259. PMID: 11472703, DOI: 10.1016/s0002-9149(01)01636-8.Peer-Reviewed Original ResearchConceptsNative coronary arteriesIntravascular ultrasound examinationBalloon-expandable stentsSE stentsCoronary arteryBE stentsMajor adverse cardiac eventsAdverse cardiac eventsBinary restenosis rateCoronary angiographic characteristicsSubgroup of patientsMinimum stent areaReduction of restenosisAngiographic characteristicsAngiographic outcomesBaseline demographicsBypass surgeryCardiac eventsRestenosis rateRestenotic lesionsIntimal proliferationIVUS analysisMyocardial infarctionUltrasound examinationLate loss
1999
Intracoronary radiation for patients with refractory in-stent restenosis An analysis from the wrist-crossover trial
Waksman R, Bhargava B, White R, Chan R, Gierlach L, Mehran R, Lansky A, Kent K, Mintz G, Satler L, Pichard A, Leon M. Intracoronary radiation for patients with refractory in-stent restenosis An analysis from the wrist-crossover trial. Cardiovascular Revascularization Medicine 1999, 1: 317-322. PMID: 10828560, DOI: 10.1016/s1522-1865(00)00024-x.Peer-Reviewed Original ResearchConceptsPrimary treatment groupTarget lesion revascularizationCrossover groupStent restenosisTreatment groupsClinical trialsQ-wave myocardial infarctionStent restenosis TrialAdverse cardiac eventsPrimary clinical endpointIntracoronary stent implantationRandomized clinical trialsCatheter-based interventionsCatheter-based techniquesStent neointimal formationAnginal symptomsLesion revascularizationRecurrent ISRRestenosis TrialActive therapyAngiographic outcomesCardiac eventsPlacebo armProcedural successIntracoronary radiation